PROVIDER PROFILE · NPI 1144299850
Martha Serven
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
263
Beneficiaries
—
Total drug cost
$138K
Distinct drugs
10
Brand share
62.4%
Top prescribed drugs
Fluticasone Propionate42 claims
Albuterol Sulfate35 claims
Montelukast Sodium31 claims
Budesonide/Formoterol Fumarate21 claims
Fluticasone Propion/Salmeterol19 claims
QUALITY · MIPS · 2024
Final MIPS score
96.6
Quality
0.0
Cost
69.9
Improvement activities
40.0
Promoting interop.
96.0
Payment adjustment
0.91%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$340
Payment records
14
By payment type
Food and Beverage$317
Consulting Fee$23
Top paying entities
Food and Beverage$317
Consulting Fee$23
REFERRAL NETWORK
Where Martha Serven's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| PEACEHEALTH | 20 | 51 |
| PEACEHEALTH | 14 | 49 |
| David Elkayam Allergy/ Immunology · Bellingham, WA | 14 | 30 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE